ESC Premium Access

Antithrombotic treatment after TAVI in patients with CAD: what matters most valve or atherosclerosis .

Congress Presentation

3 more presentations in this session

Antithrombotic treatment and valve-related outcomes (GALILEO 4D, ATLANTIS 4D): do they matter .

Thumbnail

Antithrombotic treatment after TAVI in patients without indication for anticoagulation: anything else than aspirin.

Thumbnail

Antithrombotic treatment after TAVI in patients with indication for anticoagulation.

Thumbnail

Access the full session

Antithrombotic therapy after TAVI

Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ACVC Premium Access

Pharmacological treatment: how to choose your drug (if any)

19 March 2022

ACVC Premium Access

Acute decompensated heart failure and acute pulmonary edema.

19 March 2022

ESC Premium Access

Endotrophin is significantly associated with disease severity and increased risk of adverse outcome in HFpEF but not in HFrEF patients

27 August 2021

ESC 365 is supported by

logo Novo Nordisk